Riskpilot← Back to searchSign inGet full accessTågaborgs Vårdcentral AB
ABIn liquidationOrg 5564353307General medical practice activities · NACE 8621Est. 19911 employees
Revenue 2024
SEK 2K
EBITDA margin
-25576.3%
-464% vs 2023
Equity ratio
-756.9%
Financial strength
Net profit 2024
SEK -540K
-468% vs 2023
| Revenue | SEK 2K | — |
| EBITDA | SEK -537K | -464% |
| Net profit | SEK -540K | -468% |
| Total assets | SEK 84K | -81% |
| Equity | SEK -636K | -13283% |
| Employees | 1 | — |
Legal name
Tågaborgs Vårdcentral AB
Org number
5564353307
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
5 november 1991
Share capital
SEK 100 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-06-30
Financial year
January – December
Signatory rights
Firman tecknas ensam av likvidatorn
Company purpose
Bolaget ska bedriva humanvård samt laboratorieverksamhet inom dentalbranschen, tillverkning av dentalproteser och andra ortodontiska produkter, utföra tandteknikertjänster jämte därmed förenlig verksamhet.
Address
Phone
+4642130080
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 624 | 502 | 245 | 0 | 2 |
| Staff expenses | — | — | — | −0 | −363 |
| EBITDA | 8 | −12 | −46 | −95 | −537 |
| Depreciation & amort. | −0 | −0 | −0 | — | — |
| EBIT | 8 | −12 | −46 | −95 | −537 |
| Net financials | −2 | −2 | −4 | −0 | −3 |
| Profit before tax | 5 | −14 | −30 | −95 | −540 |
| Tax | −1 | −0 | −0 | — | — |
| Net profit | 4 | −14 | −30 | −95 | −540 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 495 | 410 | 317 | 431 | 84 |
| Equity | 268 | 254 | 204 | 5 | −636 |
| Long-term debt | 0 | 0 | 78 | 6 | 6 |
| Short-term debt | 227 | 156 | 35 | 420 | 713 |
| Total debt | 227 | 156 | 113 | 427 | 720 |
EBITDA margin
-25576.3%
This company
15.8%
Market median
-161975% vs market
20202024
Equity ratio
-756.9%
This company
38.2%
Market median
-2081% vs market
20202024
Return on equity
-54035900.0%
This company
18.4%
Market median
-293673470% vs market
20202024
Net profit margin
-25731.4%
This company
8.1%
Market median
-317772% vs market
20202024
Asset turnover
0.03×
This company
1.12×
Market median
-97% vs market
20202024
Debt / equity
1.13×
This company
0.62×
Market median
-82% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-07-01 – 2020-06-30
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
PH Liquidator | Liquidator | 2026 |
| Former (1) | ||
| Audit | 2022 – 2022 | |
| Name | Role | Member since |
|---|---|---|
| Former (4) | ||
| Deputy Board Member | 2022 – 2022 | |
| Deputy Board Member | 2022 – 2026 | |
| Board of Directors | 2022 – 2022 | |
| Board of Directors | 2022 – 2026 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Tågaborgs Vårdcentral AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lars Göran Axel Johansson Gren | Audit | 0 companies |
| Pär Håkan Broomé | Liquidator | 0 companies |
| Eva Cecilia Örnå | Deputy Board Member | 0 companies |
| Sulayman Jomaa | Deputy Board Member | 0 companies |
| Sven Torsten Lundberg | Board of Directors | 0 companies |
| Kamiran Jomaa | Board of Directors | 0 companies |